Devices, disease, and digital: Holy Grail of healthcare AI

[Image courtesy of GE HealthCare]

In episode 3 of AI Meets Life Sci, DeviceTalks Managing Editor Kayleen Brown and Pharma and Biotech Editor Brian Buntz sit down with GE HealthCare Chief Digital Officer and GM of Oncology Ben Newton and Haley Schwartz of Catalyze Healthcare to discuss the impacts of AI to screen, diagnose, prognose, and treat cure disease while addressing real-world implementation issues from regulation and liability to clinician trust and adoption. They review the AI challenge of organizing disarrayed informational islands such as technology, clinical protocols, and digital solutions into cohesive, well-developed systems and offer insight into the medtech industry’s progress in this area.

Tune in and subscribe to AI Meets Life Sci on all major podcast channels and follow youtube.com/@DeviceTalks or AI Meets Life Sci YouTube Podcast to ensure you never miss an episode.

The AI Holy Grail for …
Read more
  • 0

Devices, disease, and digital: Holy Grail of healthcare AI

[Image courtesy of GE HealthCare]

In episode 3 of AI Meets Life Sci, DeviceTalks Managing Editor Kayleen Brown and Pharma and Biotech Editor Brian Buntz sit down with GE HealthCare Chief Digital Officer and GM of Oncology Ben Newton and Haley Schwartz of Catalyze Healthcare to discuss the impacts of AI to screen, diagnose, prognose, and treat cure disease while addressing real-world implementation issues from regulation and liability to clinician trust and adoption.

They review the AI challenge of organizing disarrayed informational islands such as technology, clinical protocols, and digital solutions into cohesive, well-developed systems and offer insight into the medtech industry’s progress in this area.

The AI Holy Grail for decision support

Ben Newton

AI technologies emerged quickly over the last several years in medical imaging and oncology…

Read more
  • 0

How to run a pilot program to avoid a medtech nightmare

[Photo via Adobe Stock]

Limited launches are invaluable for gathering practical insights about a product before a full-scale launch.

By Haley Schwartz, Catalyze Healthcare

Scrambling to address product limitations, clinical implementation pitfalls and competitive edges during a full-scale product launch is a painfully headache-ridden process many have experienced.

Running a smooth pilot program is imperative to uncovering these issues, creating an engineering triage plan and ultimately reducing risk to the entire launch — though flawless execution is far from easy.

Let’s dive into the key steps to define and optimize your chances of success.

Set expectations for the pilot program

First, create a plan and establish an understanding that each participating member will have to sign off and comply with the pilot’s expectations as terms of participation. Socialize this idea internally to e…

Read more
  • 0

3 reasons why your medical device won’t make it to a patient

[Photo by Quality Stock Arts – stock.adobe.com]

By Haley Schwartz, Catalyze Healthcare

Medical device innovation and commercialization is a complex, orchestrated symphony, and clinical needs, product testing and compliant scalability are the key instruments.

In this article, we explore each of these areas and how you can optimize each to harmonize the process and get your product to patients.

1. Clinical customer misalignment

Many companies fight — and lose — the battle to fundamentally align a brilliant clinical idea and true clinical requirements for widespread adoption.

For example, commoditized products such as cannulae, syringes and blood pressure cuffs are subject to the forces of distributor and group purchasing organization (GPO) contracts. On the other hand, breakthrough products are inherently subject to skepticism, long lead times to generate clinical evidence, and naysayers who…

Read more
  • 0